{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:42:54Z","timestamp":1790757774349,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jid.2017.03.025","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T18:02:13Z","timestamp":1491588133000},"page":"1766-1773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155"],"prefix":"10.1016","volume":"137","author":[{"given":"Naomi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiraku","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Miyagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Inozume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.03.025_bib1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2017.03.025_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","article-title":"Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule","volume":"198","author":"Bottino","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2017.03.025_bib3","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.4049\/jimmunol.0901226","article-title":"Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells","volume":"183","author":"Carlsten","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2017.03.025_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.coi.2012.01.009","article-title":"Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer","volume":"24","author":"Chan","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jid.2017.03.025_bib5","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1172\/JCI80445","article-title":"TIGIT and PD-1 impair tumor antigen-specific CD8\u207a T cells in melanoma patients","volume":"125","author":"Chauvin","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2017.03.025_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/icb.2013.95","article-title":"DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins","volume":"92","author":"de Andrade","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jid.2017.03.025_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","article-title":"Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides","volume":"19","author":"de Coninck","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2017.03.025_bib8","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/jid.2013.490","article-title":"CD271 on melanoma cell is an IFN-\u03b3-inducible immunosuppressive factor that mediates downregulation of melanoma antigens","volume":"134","author":"Furuta","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.03.025_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.intimp.2014.01.012","article-title":"Recombinant soluble CD226 protein directly inhibits cancer cell proliferation in\u00a0vitro","volume":"19","author":"Hou","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jid.2017.03.025_bib10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","article-title":"Mycosis fungoides and S\u00e9zary syndrome","volume":"371","author":"Hwang","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2017.03.025_bib11","doi-asserted-by":"crossref","first-page":"e0152982","DOI":"10.1371\/journal.pone.0152982","article-title":"Increased soluble CD155 in the serum of cancer patients","volume":"11","author":"Iguchi-Manaka","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2017.03.025_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/CJI.0b013e3181fad2b0","article-title":"Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells","volume":"33","author":"Inozume","year":"2010","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.jid.2017.03.025_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/JID.2015.404","article-title":"Melanoma cells control anti-melanoma CTL responses via interaction between TIGIT and CD155 in the effector phase","volume":"136","author":"Inozume","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.03.025_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.03.025_bib15","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.20021726","article-title":"Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma","volume":"197","author":"Kari","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2017.03.025_bib16","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.1103627","article-title":"The TIGIT\/CD226 axis regulates human T cell function","volume":"188","author":"Lozano","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2017.03.025_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00403-014-1501-7","article-title":"TOX expression in different subtypes of cutaneous lymphoma","volume":"306","author":"Morimura","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2017.03.025_bib18","first-page":"2287","article-title":"Clinical significance of CD155 expression in human pancreatic cancer","volume":"35","author":"Nishiwada","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jid.2017.03.025_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.molimm.2004.07.028","article-title":"PVR (CD155) and nectin-2 (CD112) as ligands of the human DNAM-1 CD226) activating receptor: involvement in tumor cell lysis","volume":"42","author":"Pende","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jid.2017.03.025_bib20","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/0008-5472.CAN-10-4179","article-title":"Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma","volume":"71","author":"Platonova","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2017.03.025_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-4-73","article-title":"CD155\/PVR plays a key role in cell motility during tumor cell invasion and migration","volume":"4","author":"Sloan","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jid.2017.03.025_bib22","doi-asserted-by":"crossref","first-page":"17858","DOI":"10.1073\/pnas.0903474106","article-title":"The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity","volume":"106","author":"Stanietsky","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2017.03.025_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2012.07.007","article-title":"Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma","volume":"68","author":"Sugaya","year":"2012","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2017.03.025_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/intimm\/dxh059","article-title":"Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2\/CD112)","volume":"16","author":"Tahara-Hanaoka","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.jid.2017.03.025_bib25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2017.03.025_bib26","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2105\/AJPH.89.8.1240","article-title":"Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality","volume":"89","author":"Weinstock","year":"1999","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jid.2017.03.025_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/imm.12516","article-title":"Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity","volume":"146","author":"Xiong","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2017.03.025_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2172-10-34","article-title":"Increased levels of soluble CD226 in sera accompanied by decreased membrane CD226 expression on peripheral blood mononuclear cells from cancer patients","volume":"10","author":"Xu","year":"2009","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jid.2017.03.025_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17314021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17314021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T03:53:08Z","timestamp":1542945188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17314021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0022202X17314021"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.03.025","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}